nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP2B6—Thiotepa—urinary bladder cancer	0.135	0.25	CbGbCtD
Sertraline—ABCB1—Mitomycin—urinary bladder cancer	0.0913	0.169	CbGbCtD
Sertraline—CYP3A4—Thiotepa—urinary bladder cancer	0.0415	0.0767	CbGbCtD
Sertraline—CYP2B6—Cisplatin—urinary bladder cancer	0.0372	0.0689	CbGbCtD
Sertraline—ABCB1—Gemcitabine—urinary bladder cancer	0.0263	0.0486	CbGbCtD
Sertraline—CYP1A2—Fluorouracil—urinary bladder cancer	0.0257	0.0476	CbGbCtD
Sertraline—CYP2B6—Doxorubicin—urinary bladder cancer	0.025	0.0462	CbGbCtD
Sertraline—CYP2C9—Fluorouracil—urinary bladder cancer	0.0232	0.0429	CbGbCtD
Sertraline—CYP1A2—Etoposide—urinary bladder cancer	0.0215	0.0397	CbGbCtD
Sertraline—CYP2C9—Cisplatin—urinary bladder cancer	0.0197	0.0364	CbGbCtD
Sertraline—ABCB1—Cisplatin—urinary bladder cancer	0.0191	0.0353	CbGbCtD
Sertraline—ABCB1—Etoposide—urinary bladder cancer	0.0188	0.0347	CbGbCtD
Sertraline—ABCB1—Doxorubicin—urinary bladder cancer	0.0128	0.0237	CbGbCtD
Sertraline—ABCB1—Methotrexate—urinary bladder cancer	0.0124	0.0229	CbGbCtD
Sertraline—CYP2D6—Doxorubicin—urinary bladder cancer	0.0121	0.0223	CbGbCtD
Sertraline—CYP3A4—Etoposide—urinary bladder cancer	0.0112	0.0208	CbGbCtD
Sertraline—CYP3A4—Doxorubicin—urinary bladder cancer	0.00767	0.0142	CbGbCtD
Sertraline—CYP2C19—urine—urinary bladder cancer	0.00474	0.0842	CbGeAlD
Sertraline—CYP1A2—urine—urinary bladder cancer	0.00387	0.0688	CbGeAlD
Sertraline—CYP2C9—urine—urinary bladder cancer	0.00367	0.0653	CbGeAlD
Sertraline—CYP3A4—urine—urinary bladder cancer	0.0028	0.0498	CbGeAlD
Sertraline—CYP2D6—urine—urinary bladder cancer	0.00276	0.049	CbGeAlD
Sertraline—SIGMAR1—prostate gland—urinary bladder cancer	0.00204	0.0362	CbGeAlD
Sertraline—MAOB—prostate gland—urinary bladder cancer	0.00195	0.0347	CbGeAlD
Sertraline—SIGMAR1—seminal vesicle—urinary bladder cancer	0.00172	0.0307	CbGeAlD
Sertraline—MAOA—prostate gland—urinary bladder cancer	0.00167	0.0296	CbGeAlD
Sertraline—MAOB—seminal vesicle—urinary bladder cancer	0.00165	0.0293	CbGeAlD
Sertraline—SIGMAR1—smooth muscle tissue—urinary bladder cancer	0.00144	0.0257	CbGeAlD
Sertraline—MAOA—seminal vesicle—urinary bladder cancer	0.00141	0.025	CbGeAlD
Sertraline—SIGMAR1—urethra—urinary bladder cancer	0.00136	0.0243	CbGeAlD
Sertraline—MAOB—renal system—urinary bladder cancer	0.00133	0.0236	CbGeAlD
Sertraline—MAOB—urethra—urinary bladder cancer	0.00131	0.0232	CbGeAlD
Sertraline—MAOA—renal system—urinary bladder cancer	0.00113	0.0202	CbGeAlD
Sertraline—SLC6A4—female reproductive system—urinary bladder cancer	0.00112	0.0199	CbGeAlD
Sertraline—MAOA—urethra—urinary bladder cancer	0.00111	0.0198	CbGeAlD
Sertraline—MAOB—female reproductive system—urinary bladder cancer	0.00107	0.0189	CbGeAlD
Sertraline—SIGMAR1—vagina—urinary bladder cancer	0.00101	0.0179	CbGeAlD
Sertraline—SLC6A2—female reproductive system—urinary bladder cancer	0.000987	0.0175	CbGeAlD
Sertraline—MAOB—vagina—urinary bladder cancer	0.000963	0.0171	CbGeAlD
Sertraline—CYP1A2—renal system—urinary bladder cancer	0.000947	0.0168	CbGeAlD
Sertraline—MAOA—female reproductive system—urinary bladder cancer	0.000909	0.0162	CbGeAlD
Sertraline—CYP2B6—renal system—urinary bladder cancer	0.000908	0.0161	CbGeAlD
Sertraline—CYP2C19—vagina—urinary bladder cancer	0.00084	0.0149	CbGeAlD
Sertraline—MAOA—vagina—urinary bladder cancer	0.000822	0.0146	CbGeAlD
Sertraline—CYP2B6—female reproductive system—urinary bladder cancer	0.000727	0.0129	CbGeAlD
Sertraline—CYP2C9—female reproductive system—urinary bladder cancer	0.00072	0.0128	CbGeAlD
Sertraline—ABCB1—prostate gland—urinary bladder cancer	0.000712	0.0127	CbGeAlD
Sertraline—CYP3A4—renal system—urinary bladder cancer	0.000685	0.0122	CbGeAlD
Sertraline—CYP2D6—renal system—urinary bladder cancer	0.000674	0.012	CbGeAlD
Sertraline—CYP2B6—vagina—urinary bladder cancer	0.000657	0.0117	CbGeAlD
Sertraline—SIGMAR1—lymph node—urinary bladder cancer	0.000651	0.0116	CbGeAlD
Sertraline—MAOB—lymph node—urinary bladder cancer	0.000623	0.0111	CbGeAlD
Sertraline—ABCB1—seminal vesicle—urinary bladder cancer	0.000602	0.0107	CbGeAlD
Sertraline—SLC6A2—lymph node—urinary bladder cancer	0.000577	0.0103	CbGeAlD
Sertraline—CYP3A4—female reproductive system—urinary bladder cancer	0.000549	0.00976	CbGeAlD
Sertraline—CYP2D6—female reproductive system—urinary bladder cancer	0.00054	0.0096	CbGeAlD
Sertraline—MAOA—lymph node—urinary bladder cancer	0.000532	0.00945	CbGeAlD
Sertraline—ABCB1—epithelium—urinary bladder cancer	0.000523	0.0093	CbGeAlD
Sertraline—ABCB1—renal system—urinary bladder cancer	0.000485	0.00863	CbGeAlD
Sertraline—ABCB1—urethra—urinary bladder cancer	0.000477	0.00847	CbGeAlD
Sertraline—ABCB1—female reproductive system—urinary bladder cancer	0.000389	0.00691	CbGeAlD
Sertraline—ABCB1—vagina—urinary bladder cancer	0.000351	0.00625	CbGeAlD
Sertraline—ABCB1—lymph node—urinary bladder cancer	0.000227	0.00404	CbGeAlD
Sertraline—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000117	0.0004	CcSEcCtD
Sertraline—Epistaxis—Doxorubicin—urinary bladder cancer	0.000117	0.000399	CcSEcCtD
Sertraline—Angiopathy—Methotrexate—urinary bladder cancer	0.000117	0.000398	CcSEcCtD
Sertraline—Sinusitis—Doxorubicin—urinary bladder cancer	0.000116	0.000397	CcSEcCtD
Sertraline—Immune system disorder—Methotrexate—urinary bladder cancer	0.000116	0.000396	CcSEcCtD
Sertraline—Dizziness—Fluorouracil—urinary bladder cancer	0.000116	0.000396	CcSEcCtD
Sertraline—Visual impairment—Epirubicin—urinary bladder cancer	0.000116	0.000395	CcSEcCtD
Sertraline—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000116	0.000395	CcSEcCtD
Sertraline—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000116	0.000394	CcSEcCtD
Sertraline—Chills—Methotrexate—urinary bladder cancer	0.000115	0.000393	CcSEcCtD
Sertraline—Diarrhoea—Cisplatin—urinary bladder cancer	0.000114	0.000388	CcSEcCtD
Sertraline—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000114	0.000388	CcSEcCtD
Sertraline—Alopecia—Methotrexate—urinary bladder cancer	0.000114	0.000387	CcSEcCtD
Sertraline—Vomiting—Gemcitabine—urinary bladder cancer	0.000114	0.000387	CcSEcCtD
Sertraline—Bradycardia—Doxorubicin—urinary bladder cancer	0.000113	0.000386	CcSEcCtD
Sertraline—Mental disorder—Methotrexate—urinary bladder cancer	0.000113	0.000384	CcSEcCtD
Sertraline—Rash—Gemcitabine—urinary bladder cancer	0.000113	0.000384	CcSEcCtD
Sertraline—Dermatitis—Gemcitabine—urinary bladder cancer	0.000113	0.000383	CcSEcCtD
Sertraline—Eye disorder—Epirubicin—urinary bladder cancer	0.000112	0.000383	CcSEcCtD
Sertraline—Hypersensitivity—Etoposide—urinary bladder cancer	0.000112	0.000383	CcSEcCtD
Sertraline—Tinnitus—Epirubicin—urinary bladder cancer	0.000112	0.000382	CcSEcCtD
Sertraline—Erythema—Methotrexate—urinary bladder cancer	0.000112	0.000381	CcSEcCtD
Sertraline—Malnutrition—Methotrexate—urinary bladder cancer	0.000112	0.000381	CcSEcCtD
Sertraline—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000112	0.000381	CcSEcCtD
Sertraline—Headache—Gemcitabine—urinary bladder cancer	0.000112	0.000381	CcSEcCtD
Sertraline—Flushing—Epirubicin—urinary bladder cancer	0.000112	0.000381	CcSEcCtD
Sertraline—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000112	0.000381	CcSEcCtD
Sertraline—Vomiting—Fluorouracil—urinary bladder cancer	0.000112	0.000381	CcSEcCtD
Sertraline—Rhinitis—Doxorubicin—urinary bladder cancer	0.000112	0.00038	CcSEcCtD
Sertraline—Hepatitis—Doxorubicin—urinary bladder cancer	0.000111	0.000379	CcSEcCtD
Sertraline—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000111	0.000379	CcSEcCtD
Sertraline—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000111	0.000378	CcSEcCtD
Sertraline—Rash—Fluorouracil—urinary bladder cancer	0.000111	0.000377	CcSEcCtD
Sertraline—Dermatitis—Fluorouracil—urinary bladder cancer	0.000111	0.000377	CcSEcCtD
Sertraline—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000111	0.000377	CcSEcCtD
Sertraline—Headache—Fluorouracil—urinary bladder cancer	0.00011	0.000375	CcSEcCtD
Sertraline—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00011	0.000375	CcSEcCtD
Sertraline—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00011	0.000374	CcSEcCtD
Sertraline—Dysgeusia—Methotrexate—urinary bladder cancer	0.00011	0.000374	CcSEcCtD
Sertraline—Asthenia—Etoposide—urinary bladder cancer	0.000109	0.000373	CcSEcCtD
Sertraline—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000109	0.000373	CcSEcCtD
Sertraline—Angiopathy—Epirubicin—urinary bladder cancer	0.000109	0.000372	CcSEcCtD
Sertraline—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000109	0.000372	CcSEcCtD
Sertraline—Immune system disorder—Epirubicin—urinary bladder cancer	0.000109	0.00037	CcSEcCtD
Sertraline—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000108	0.00037	CcSEcCtD
Sertraline—Back pain—Methotrexate—urinary bladder cancer	0.000108	0.000369	CcSEcCtD
Sertraline—Chills—Epirubicin—urinary bladder cancer	0.000108	0.000368	CcSEcCtD
Sertraline—Pruritus—Etoposide—urinary bladder cancer	0.000108	0.000368	CcSEcCtD
Sertraline—Arrhythmia—Epirubicin—urinary bladder cancer	0.000107	0.000366	CcSEcCtD
Sertraline—Visual impairment—Doxorubicin—urinary bladder cancer	0.000107	0.000366	CcSEcCtD
Sertraline—Alopecia—Epirubicin—urinary bladder cancer	0.000106	0.000362	CcSEcCtD
Sertraline—Nausea—Gemcitabine—urinary bladder cancer	0.000106	0.000362	CcSEcCtD
Sertraline—Vomiting—Cisplatin—urinary bladder cancer	0.000106	0.000361	CcSEcCtD
Sertraline—Mental disorder—Epirubicin—urinary bladder cancer	0.000105	0.000359	CcSEcCtD
Sertraline—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000105	0.000359	CcSEcCtD
Sertraline—Rash—Cisplatin—urinary bladder cancer	0.000105	0.000358	CcSEcCtD
Sertraline—Dermatitis—Cisplatin—urinary bladder cancer	0.000105	0.000357	CcSEcCtD
Sertraline—Erythema—Epirubicin—urinary bladder cancer	0.000105	0.000357	CcSEcCtD
Sertraline—Malnutrition—Epirubicin—urinary bladder cancer	0.000105	0.000357	CcSEcCtD
Sertraline—Diarrhoea—Etoposide—urinary bladder cancer	0.000104	0.000356	CcSEcCtD
Sertraline—Nausea—Fluorouracil—urinary bladder cancer	0.000104	0.000355	CcSEcCtD
Sertraline—Eye disorder—Doxorubicin—urinary bladder cancer	0.000104	0.000355	CcSEcCtD
Sertraline—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000104	0.000354	CcSEcCtD
Sertraline—Tinnitus—Doxorubicin—urinary bladder cancer	0.000104	0.000354	CcSEcCtD
Sertraline—Anaemia—Methotrexate—urinary bladder cancer	0.000103	0.000353	CcSEcCtD
Sertraline—Flushing—Doxorubicin—urinary bladder cancer	0.000103	0.000352	CcSEcCtD
Sertraline—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000103	0.000352	CcSEcCtD
Sertraline—Flatulence—Epirubicin—urinary bladder cancer	0.000103	0.000352	CcSEcCtD
Sertraline—Tension—Epirubicin—urinary bladder cancer	0.000103	0.00035	CcSEcCtD
Sertraline—Dysgeusia—Epirubicin—urinary bladder cancer	0.000103	0.00035	CcSEcCtD
Sertraline—Nervousness—Epirubicin—urinary bladder cancer	0.000102	0.000347	CcSEcCtD
Sertraline—Back pain—Epirubicin—urinary bladder cancer	0.000101	0.000345	CcSEcCtD
Sertraline—Angiopathy—Doxorubicin—urinary bladder cancer	0.000101	0.000344	CcSEcCtD
Sertraline—Malaise—Methotrexate—urinary bladder cancer	0.000101	0.000344	CcSEcCtD
Sertraline—Dizziness—Etoposide—urinary bladder cancer	0.000101	0.000344	CcSEcCtD
Sertraline—Muscle spasms—Epirubicin—urinary bladder cancer	0.000101	0.000343	CcSEcCtD
Sertraline—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000101	0.000343	CcSEcCtD
Sertraline—Vertigo—Methotrexate—urinary bladder cancer	0.000101	0.000343	CcSEcCtD
Sertraline—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.0001	0.000342	CcSEcCtD
Sertraline—Leukopenia—Methotrexate—urinary bladder cancer	0.0001	0.000341	CcSEcCtD
Sertraline—Chills—Doxorubicin—urinary bladder cancer	9.99e-05	0.00034	CcSEcCtD
Sertraline—Arrhythmia—Doxorubicin—urinary bladder cancer	9.95e-05	0.000339	CcSEcCtD
Sertraline—Nausea—Cisplatin—urinary bladder cancer	9.89e-05	0.000337	CcSEcCtD
Sertraline—Alopecia—Doxorubicin—urinary bladder cancer	9.84e-05	0.000335	CcSEcCtD
Sertraline—Cough—Methotrexate—urinary bladder cancer	9.77e-05	0.000333	CcSEcCtD
Sertraline—Mental disorder—Doxorubicin—urinary bladder cancer	9.75e-05	0.000332	CcSEcCtD
Sertraline—Ill-defined disorder—Epirubicin—urinary bladder cancer	9.72e-05	0.000331	CcSEcCtD
Sertraline—Convulsion—Methotrexate—urinary bladder cancer	9.7e-05	0.00033	CcSEcCtD
Sertraline—Vomiting—Etoposide—urinary bladder cancer	9.7e-05	0.00033	CcSEcCtD
Sertraline—Malnutrition—Doxorubicin—urinary bladder cancer	9.69e-05	0.00033	CcSEcCtD
Sertraline—Erythema—Doxorubicin—urinary bladder cancer	9.69e-05	0.00033	CcSEcCtD
Sertraline—Anaemia—Epirubicin—urinary bladder cancer	9.68e-05	0.00033	CcSEcCtD
Sertraline—Agitation—Epirubicin—urinary bladder cancer	9.63e-05	0.000328	CcSEcCtD
Sertraline—Rash—Etoposide—urinary bladder cancer	9.62e-05	0.000328	CcSEcCtD
Sertraline—Dermatitis—Etoposide—urinary bladder cancer	9.61e-05	0.000327	CcSEcCtD
Sertraline—Headache—Etoposide—urinary bladder cancer	9.55e-05	0.000326	CcSEcCtD
Sertraline—Flatulence—Doxorubicin—urinary bladder cancer	9.55e-05	0.000325	CcSEcCtD
Sertraline—Chest pain—Methotrexate—urinary bladder cancer	9.53e-05	0.000325	CcSEcCtD
Sertraline—Arthralgia—Methotrexate—urinary bladder cancer	9.53e-05	0.000325	CcSEcCtD
Sertraline—Myalgia—Methotrexate—urinary bladder cancer	9.53e-05	0.000325	CcSEcCtD
Sertraline—Tension—Doxorubicin—urinary bladder cancer	9.51e-05	0.000324	CcSEcCtD
Sertraline—Dysgeusia—Doxorubicin—urinary bladder cancer	9.49e-05	0.000323	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	9.46e-05	0.000323	CcSEcCtD
Sertraline—Malaise—Epirubicin—urinary bladder cancer	9.45e-05	0.000322	CcSEcCtD
Sertraline—Discomfort—Methotrexate—urinary bladder cancer	9.42e-05	0.000321	CcSEcCtD
Sertraline—Nervousness—Doxorubicin—urinary bladder cancer	9.41e-05	0.000321	CcSEcCtD
Sertraline—Vertigo—Epirubicin—urinary bladder cancer	9.41e-05	0.000321	CcSEcCtD
Sertraline—Syncope—Epirubicin—urinary bladder cancer	9.39e-05	0.00032	CcSEcCtD
Sertraline—Leukopenia—Epirubicin—urinary bladder cancer	9.38e-05	0.00032	CcSEcCtD
Sertraline—Back pain—Doxorubicin—urinary bladder cancer	9.38e-05	0.000319	CcSEcCtD
Sertraline—Muscle spasms—Doxorubicin—urinary bladder cancer	9.32e-05	0.000318	CcSEcCtD
Sertraline—Palpitations—Epirubicin—urinary bladder cancer	9.26e-05	0.000315	CcSEcCtD
Sertraline—Confusional state—Methotrexate—urinary bladder cancer	9.21e-05	0.000314	CcSEcCtD
Sertraline—Loss of consciousness—Epirubicin—urinary bladder cancer	9.21e-05	0.000314	CcSEcCtD
Sertraline—Cough—Epirubicin—urinary bladder cancer	9.14e-05	0.000312	CcSEcCtD
Sertraline—Anaphylactic shock—Methotrexate—urinary bladder cancer	9.14e-05	0.000311	CcSEcCtD
Sertraline—Convulsion—Epirubicin—urinary bladder cancer	9.08e-05	0.000309	CcSEcCtD
Sertraline—Nausea—Etoposide—urinary bladder cancer	9.06e-05	0.000309	CcSEcCtD
Sertraline—Hypertension—Epirubicin—urinary bladder cancer	9.04e-05	0.000308	CcSEcCtD
Sertraline—Ill-defined disorder—Doxorubicin—urinary bladder cancer	8.99e-05	0.000306	CcSEcCtD
Sertraline—Nervous system disorder—Methotrexate—urinary bladder cancer	8.96e-05	0.000305	CcSEcCtD
Sertraline—Anaemia—Doxorubicin—urinary bladder cancer	8.96e-05	0.000305	CcSEcCtD
Sertraline—Thrombocytopenia—Methotrexate—urinary bladder cancer	8.94e-05	0.000305	CcSEcCtD
Sertraline—Arthralgia—Epirubicin—urinary bladder cancer	8.92e-05	0.000304	CcSEcCtD
Sertraline—Myalgia—Epirubicin—urinary bladder cancer	8.92e-05	0.000304	CcSEcCtD
Sertraline—Chest pain—Epirubicin—urinary bladder cancer	8.92e-05	0.000304	CcSEcCtD
Sertraline—Agitation—Doxorubicin—urinary bladder cancer	8.91e-05	0.000304	CcSEcCtD
Sertraline—Anxiety—Epirubicin—urinary bladder cancer	8.89e-05	0.000303	CcSEcCtD
Sertraline—Skin disorder—Methotrexate—urinary bladder cancer	8.87e-05	0.000302	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	8.86e-05	0.000302	CcSEcCtD
Sertraline—Hyperhidrosis—Methotrexate—urinary bladder cancer	8.83e-05	0.000301	CcSEcCtD
Sertraline—Discomfort—Epirubicin—urinary bladder cancer	8.81e-05	0.0003	CcSEcCtD
Sertraline—Malaise—Doxorubicin—urinary bladder cancer	8.74e-05	0.000298	CcSEcCtD
Sertraline—Dry mouth—Epirubicin—urinary bladder cancer	8.72e-05	0.000297	CcSEcCtD
Sertraline—Vertigo—Doxorubicin—urinary bladder cancer	8.71e-05	0.000297	CcSEcCtD
Sertraline—Anorexia—Methotrexate—urinary bladder cancer	8.71e-05	0.000297	CcSEcCtD
Sertraline—Syncope—Doxorubicin—urinary bladder cancer	8.69e-05	0.000296	CcSEcCtD
Sertraline—Leukopenia—Doxorubicin—urinary bladder cancer	8.68e-05	0.000296	CcSEcCtD
Sertraline—Confusional state—Epirubicin—urinary bladder cancer	8.62e-05	0.000294	CcSEcCtD
Sertraline—Palpitations—Doxorubicin—urinary bladder cancer	8.56e-05	0.000292	CcSEcCtD
Sertraline—Oedema—Epirubicin—urinary bladder cancer	8.55e-05	0.000291	CcSEcCtD
Sertraline—Anaphylactic shock—Epirubicin—urinary bladder cancer	8.55e-05	0.000291	CcSEcCtD
Sertraline—Hypotension—Methotrexate—urinary bladder cancer	8.54e-05	0.000291	CcSEcCtD
Sertraline—Loss of consciousness—Doxorubicin—urinary bladder cancer	8.52e-05	0.00029	CcSEcCtD
Sertraline—Cough—Doxorubicin—urinary bladder cancer	8.46e-05	0.000288	CcSEcCtD
Sertraline—Shock—Epirubicin—urinary bladder cancer	8.41e-05	0.000287	CcSEcCtD
Sertraline—Convulsion—Doxorubicin—urinary bladder cancer	8.4e-05	0.000286	CcSEcCtD
Sertraline—Nervous system disorder—Epirubicin—urinary bladder cancer	8.38e-05	0.000286	CcSEcCtD
Sertraline—Thrombocytopenia—Epirubicin—urinary bladder cancer	8.37e-05	0.000285	CcSEcCtD
Sertraline—Hypertension—Doxorubicin—urinary bladder cancer	8.37e-05	0.000285	CcSEcCtD
Sertraline—Tachycardia—Epirubicin—urinary bladder cancer	8.34e-05	0.000284	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	8.32e-05	0.000284	CcSEcCtD
Sertraline—Skin disorder—Epirubicin—urinary bladder cancer	8.3e-05	0.000283	CcSEcCtD
Sertraline—Hyperhidrosis—Epirubicin—urinary bladder cancer	8.26e-05	0.000282	CcSEcCtD
Sertraline—Insomnia—Methotrexate—urinary bladder cancer	8.26e-05	0.000282	CcSEcCtD
Sertraline—Arthralgia—Doxorubicin—urinary bladder cancer	8.25e-05	0.000281	CcSEcCtD
Sertraline—Chest pain—Doxorubicin—urinary bladder cancer	8.25e-05	0.000281	CcSEcCtD
Sertraline—Myalgia—Doxorubicin—urinary bladder cancer	8.25e-05	0.000281	CcSEcCtD
Sertraline—Anxiety—Doxorubicin—urinary bladder cancer	8.22e-05	0.00028	CcSEcCtD
Sertraline—Paraesthesia—Methotrexate—urinary bladder cancer	8.2e-05	0.00028	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	8.19e-05	0.000279	CcSEcCtD
Sertraline—Discomfort—Doxorubicin—urinary bladder cancer	8.15e-05	0.000278	CcSEcCtD
Sertraline—Anorexia—Epirubicin—urinary bladder cancer	8.15e-05	0.000278	CcSEcCtD
Sertraline—Dyspnoea—Methotrexate—urinary bladder cancer	8.14e-05	0.000278	CcSEcCtD
Sertraline—Somnolence—Methotrexate—urinary bladder cancer	8.12e-05	0.000277	CcSEcCtD
Sertraline—Dry mouth—Doxorubicin—urinary bladder cancer	8.07e-05	0.000275	CcSEcCtD
Sertraline—Dyspepsia—Methotrexate—urinary bladder cancer	8.04e-05	0.000274	CcSEcCtD
Sertraline—Hypotension—Epirubicin—urinary bladder cancer	7.99e-05	0.000272	CcSEcCtD
Sertraline—Confusional state—Doxorubicin—urinary bladder cancer	7.98e-05	0.000272	CcSEcCtD
Sertraline—Decreased appetite—Methotrexate—urinary bladder cancer	7.94e-05	0.000271	CcSEcCtD
Sertraline—Anaphylactic shock—Doxorubicin—urinary bladder cancer	7.91e-05	0.00027	CcSEcCtD
Sertraline—Oedema—Doxorubicin—urinary bladder cancer	7.91e-05	0.00027	CcSEcCtD
Sertraline—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	7.89e-05	0.000269	CcSEcCtD
Sertraline—Fatigue—Methotrexate—urinary bladder cancer	7.88e-05	0.000268	CcSEcCtD
Sertraline—Pain—Methotrexate—urinary bladder cancer	7.81e-05	0.000266	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	7.79e-05	0.000265	CcSEcCtD
Sertraline—Shock—Doxorubicin—urinary bladder cancer	7.78e-05	0.000265	CcSEcCtD
Sertraline—Nervous system disorder—Doxorubicin—urinary bladder cancer	7.76e-05	0.000264	CcSEcCtD
Sertraline—Thrombocytopenia—Doxorubicin—urinary bladder cancer	7.74e-05	0.000264	CcSEcCtD
Sertraline—Insomnia—Epirubicin—urinary bladder cancer	7.73e-05	0.000264	CcSEcCtD
Sertraline—Tachycardia—Doxorubicin—urinary bladder cancer	7.72e-05	0.000263	CcSEcCtD
Sertraline—Skin disorder—Doxorubicin—urinary bladder cancer	7.68e-05	0.000262	CcSEcCtD
Sertraline—Paraesthesia—Epirubicin—urinary bladder cancer	7.68e-05	0.000262	CcSEcCtD
Sertraline—Hyperhidrosis—Doxorubicin—urinary bladder cancer	7.65e-05	0.000261	CcSEcCtD
Sertraline—Dyspnoea—Epirubicin—urinary bladder cancer	7.62e-05	0.00026	CcSEcCtD
Sertraline—Somnolence—Epirubicin—urinary bladder cancer	7.6e-05	0.000259	CcSEcCtD
Sertraline—Anorexia—Doxorubicin—urinary bladder cancer	7.54e-05	0.000257	CcSEcCtD
Sertraline—Feeling abnormal—Methotrexate—urinary bladder cancer	7.53e-05	0.000257	CcSEcCtD
Sertraline—Dyspepsia—Epirubicin—urinary bladder cancer	7.53e-05	0.000256	CcSEcCtD
Sertraline—Gastrointestinal pain—Methotrexate—urinary bladder cancer	7.47e-05	0.000255	CcSEcCtD
Sertraline—Decreased appetite—Epirubicin—urinary bladder cancer	7.43e-05	0.000253	CcSEcCtD
Sertraline—Hypotension—Doxorubicin—urinary bladder cancer	7.39e-05	0.000252	CcSEcCtD
Sertraline—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	7.38e-05	0.000252	CcSEcCtD
Sertraline—Fatigue—Epirubicin—urinary bladder cancer	7.37e-05	0.000251	CcSEcCtD
Sertraline—Pain—Epirubicin—urinary bladder cancer	7.31e-05	0.000249	CcSEcCtD
Sertraline—Constipation—Epirubicin—urinary bladder cancer	7.31e-05	0.000249	CcSEcCtD
Sertraline—Urticaria—Methotrexate—urinary bladder cancer	7.26e-05	0.000247	CcSEcCtD
Sertraline—Abdominal pain—Methotrexate—urinary bladder cancer	7.22e-05	0.000246	CcSEcCtD
Sertraline—Body temperature increased—Methotrexate—urinary bladder cancer	7.22e-05	0.000246	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	7.21e-05	0.000246	CcSEcCtD
Sertraline—Insomnia—Doxorubicin—urinary bladder cancer	7.15e-05	0.000244	CcSEcCtD
Sertraline—Paraesthesia—Doxorubicin—urinary bladder cancer	7.1e-05	0.000242	CcSEcCtD
Sertraline—Dyspnoea—Doxorubicin—urinary bladder cancer	7.05e-05	0.00024	CcSEcCtD
Sertraline—Feeling abnormal—Epirubicin—urinary bladder cancer	7.04e-05	0.00024	CcSEcCtD
Sertraline—Somnolence—Doxorubicin—urinary bladder cancer	7.03e-05	0.00024	CcSEcCtD
Sertraline—Gastrointestinal pain—Epirubicin—urinary bladder cancer	6.99e-05	0.000238	CcSEcCtD
Sertraline—Dyspepsia—Doxorubicin—urinary bladder cancer	6.96e-05	0.000237	CcSEcCtD
Sertraline—Decreased appetite—Doxorubicin—urinary bladder cancer	6.88e-05	0.000234	CcSEcCtD
Sertraline—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	6.83e-05	0.000233	CcSEcCtD
Sertraline—Fatigue—Doxorubicin—urinary bladder cancer	6.82e-05	0.000232	CcSEcCtD
Sertraline—Urticaria—Epirubicin—urinary bladder cancer	6.79e-05	0.000231	CcSEcCtD
Sertraline—Pain—Doxorubicin—urinary bladder cancer	6.76e-05	0.000231	CcSEcCtD
Sertraline—Constipation—Doxorubicin—urinary bladder cancer	6.76e-05	0.000231	CcSEcCtD
Sertraline—Body temperature increased—Epirubicin—urinary bladder cancer	6.76e-05	0.00023	CcSEcCtD
Sertraline—Abdominal pain—Epirubicin—urinary bladder cancer	6.76e-05	0.00023	CcSEcCtD
Sertraline—Hypersensitivity—Methotrexate—urinary bladder cancer	6.73e-05	0.000229	CcSEcCtD
Sertraline—Asthenia—Methotrexate—urinary bladder cancer	6.55e-05	0.000223	CcSEcCtD
Sertraline—Feeling abnormal—Doxorubicin—urinary bladder cancer	6.52e-05	0.000222	CcSEcCtD
Sertraline—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	6.47e-05	0.00022	CcSEcCtD
Sertraline—Pruritus—Methotrexate—urinary bladder cancer	6.46e-05	0.00022	CcSEcCtD
Sertraline—Hypersensitivity—Epirubicin—urinary bladder cancer	6.3e-05	0.000215	CcSEcCtD
Sertraline—Urticaria—Doxorubicin—urinary bladder cancer	6.28e-05	0.000214	CcSEcCtD
Sertraline—Abdominal pain—Doxorubicin—urinary bladder cancer	6.25e-05	0.000213	CcSEcCtD
Sertraline—Body temperature increased—Doxorubicin—urinary bladder cancer	6.25e-05	0.000213	CcSEcCtD
Sertraline—Diarrhoea—Methotrexate—urinary bladder cancer	6.25e-05	0.000213	CcSEcCtD
Sertraline—Asthenia—Epirubicin—urinary bladder cancer	6.13e-05	0.000209	CcSEcCtD
Sertraline—Pruritus—Epirubicin—urinary bladder cancer	6.05e-05	0.000206	CcSEcCtD
Sertraline—Dizziness—Methotrexate—urinary bladder cancer	6.04e-05	0.000206	CcSEcCtD
Sertraline—Diarrhoea—Epirubicin—urinary bladder cancer	5.85e-05	0.000199	CcSEcCtD
Sertraline—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.83e-05	0.000199	CcSEcCtD
Sertraline—Vomiting—Methotrexate—urinary bladder cancer	5.81e-05	0.000198	CcSEcCtD
Sertraline—Rash—Methotrexate—urinary bladder cancer	5.76e-05	0.000196	CcSEcCtD
Sertraline—Dermatitis—Methotrexate—urinary bladder cancer	5.75e-05	0.000196	CcSEcCtD
Sertraline—Headache—Methotrexate—urinary bladder cancer	5.72e-05	0.000195	CcSEcCtD
Sertraline—Asthenia—Doxorubicin—urinary bladder cancer	5.68e-05	0.000193	CcSEcCtD
Sertraline—Dizziness—Epirubicin—urinary bladder cancer	5.65e-05	0.000193	CcSEcCtD
Sertraline—Pruritus—Doxorubicin—urinary bladder cancer	5.6e-05	0.000191	CcSEcCtD
Sertraline—Vomiting—Epirubicin—urinary bladder cancer	5.44e-05	0.000185	CcSEcCtD
Sertraline—Nausea—Methotrexate—urinary bladder cancer	5.43e-05	0.000185	CcSEcCtD
Sertraline—Diarrhoea—Doxorubicin—urinary bladder cancer	5.41e-05	0.000184	CcSEcCtD
Sertraline—Rash—Epirubicin—urinary bladder cancer	5.39e-05	0.000184	CcSEcCtD
Sertraline—Dermatitis—Epirubicin—urinary bladder cancer	5.39e-05	0.000184	CcSEcCtD
Sertraline—Headache—Epirubicin—urinary bladder cancer	5.36e-05	0.000183	CcSEcCtD
Sertraline—Dizziness—Doxorubicin—urinary bladder cancer	5.23e-05	0.000178	CcSEcCtD
Sertraline—Nausea—Epirubicin—urinary bladder cancer	5.08e-05	0.000173	CcSEcCtD
Sertraline—Vomiting—Doxorubicin—urinary bladder cancer	5.03e-05	0.000171	CcSEcCtD
Sertraline—Rash—Doxorubicin—urinary bladder cancer	4.99e-05	0.00017	CcSEcCtD
Sertraline—Dermatitis—Doxorubicin—urinary bladder cancer	4.98e-05	0.00017	CcSEcCtD
Sertraline—Headache—Doxorubicin—urinary bladder cancer	4.96e-05	0.000169	CcSEcCtD
Sertraline—Nausea—Doxorubicin—urinary bladder cancer	4.7e-05	0.00016	CcSEcCtD
Sertraline—CYP2C19—Metabolism—NAT1—urinary bladder cancer	4.32e-05	0.000392	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	4.32e-05	0.000392	CbGpPWpGaD
Sertraline—MAOA—Metabolism—RRM2—urinary bladder cancer	4.31e-05	0.000392	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTP1—urinary bladder cancer	4.28e-05	0.000389	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.24e-05	0.000386	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4.22e-05	0.000384	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTO2—urinary bladder cancer	4.21e-05	0.000383	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NAT1—urinary bladder cancer	4.21e-05	0.000383	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	4.19e-05	0.000381	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.17e-05	0.000379	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	4.15e-05	0.000377	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.11e-05	0.000373	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.1e-05	0.000373	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.05e-05	0.000368	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ENO2—urinary bladder cancer	3.99e-05	0.000363	CbGpPWpGaD
Sertraline—MAOA—Metabolism—HPGDS—urinary bladder cancer	3.99e-05	0.000363	CbGpPWpGaD
Sertraline—MAOB—Metabolism—TYMS—urinary bladder cancer	3.98e-05	0.000362	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	3.97e-05	0.000361	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NAT1—urinary bladder cancer	3.97e-05	0.000361	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	3.95e-05	0.000359	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	3.94e-05	0.000358	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NAT1—urinary bladder cancer	3.94e-05	0.000358	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTM1—urinary bladder cancer	3.93e-05	0.000357	CbGpPWpGaD
Sertraline—MAOB—Metabolism—NCOR1—urinary bladder cancer	3.93e-05	0.000357	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTT1—urinary bladder cancer	3.87e-05	0.000352	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.87e-05	0.000352	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.85e-05	0.00035	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.81e-05	0.000347	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.81e-05	0.000346	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GPX1—urinary bladder cancer	3.77e-05	0.000342	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ERCC2—urinary bladder cancer	3.7e-05	0.000336	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	3.63e-05	0.00033	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	3.6e-05	0.000327	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.58e-05	0.000325	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	3.55e-05	0.000323	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	3.55e-05	0.000322	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.53e-05	0.000321	CbGpPWpGaD
Sertraline—MAOB—Metabolism—MTHFR—urinary bladder cancer	3.48e-05	0.000316	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.47e-05	0.000315	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—TYMP—urinary bladder cancer	3.46e-05	0.000315	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.46e-05	0.000314	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.37e-05	0.000306	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	3.36e-05	0.000306	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NAT1—urinary bladder cancer	3.36e-05	0.000306	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.36e-05	0.000305	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.31e-05	0.000301	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.28e-05	0.000298	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.27e-05	0.000297	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	3.27e-05	0.000297	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.24e-05	0.000295	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NQO1—urinary bladder cancer	3.22e-05	0.000293	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.19e-05	0.00029	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—HRAS—urinary bladder cancer	3.14e-05	0.000286	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NAT2—urinary bladder cancer	3.13e-05	0.000284	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.12e-05	0.000284	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	3.09e-05	0.000281	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	3.08e-05	0.00028	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.06e-05	0.000278	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.02e-05	0.000275	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.01e-05	0.000274	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	3.01e-05	0.000273	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	2.98e-05	0.000271	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—HRAS—urinary bladder cancer	2.92e-05	0.000266	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.87e-05	0.000261	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PPARG—urinary bladder cancer	2.82e-05	0.000256	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.79e-05	0.000254	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	2.77e-05	0.000252	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.74e-05	0.000249	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CREBBP—urinary bladder cancer	2.71e-05	0.000246	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—RRM2—urinary bladder cancer	2.7e-05	0.000246	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTP1—urinary bladder cancer	2.69e-05	0.000244	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.62e-05	0.000238	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	2.62e-05	0.000238	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.61e-05	0.000238	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.6e-05	0.000236	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.6e-05	0.000236	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.55e-05	0.000232	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	2.55e-05	0.000232	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.51e-05	0.000228	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.5e-05	0.000228	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.5e-05	0.000227	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.5e-05	0.000227	CbGpPWpGaD
Sertraline—MAOA—Metabolism—TYMS—urinary bladder cancer	2.5e-05	0.000227	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NCOR1—urinary bladder cancer	2.47e-05	0.000224	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTM1—urinary bladder cancer	2.47e-05	0.000224	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.45e-05	0.000223	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.43e-05	0.000221	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TYMP—urinary bladder cancer	2.41e-05	0.000219	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.39e-05	0.000217	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.38e-05	0.000217	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.37e-05	0.000216	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.36e-05	0.000215	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GPX1—urinary bladder cancer	2.36e-05	0.000215	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.33e-05	0.000212	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ERCC2—urinary bladder cancer	2.32e-05	0.000211	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.31e-05	0.00021	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.31e-05	0.00021	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.29e-05	0.000208	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTGS2—urinary bladder cancer	2.22e-05	0.000201	CbGpPWpGaD
Sertraline—MAOA—Metabolism—MTHFR—urinary bladder cancer	2.18e-05	0.000198	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.18e-05	0.000198	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.16e-05	0.000196	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.14e-05	0.000194	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.06e-05	0.000187	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.04e-05	0.000186	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.04e-05	0.000186	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.04e-05	0.000185	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.02e-05	0.000183	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.02e-05	0.000183	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.99e-05	0.000181	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.97e-05	0.000179	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.96e-05	0.000178	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTEN—urinary bladder cancer	1.93e-05	0.000176	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.89e-05	0.000172	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.89e-05	0.000172	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.88e-05	0.000171	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.88e-05	0.000171	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.86e-05	0.000169	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.85e-05	0.000168	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.85e-05	0.000168	CbGpPWpGaD
Sertraline—MAOB—Metabolism—EP300—urinary bladder cancer	1.84e-05	0.000168	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.84e-05	0.000167	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.83e-05	0.000167	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.81e-05	0.000164	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.79e-05	0.000163	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PPARG—urinary bladder cancer	1.77e-05	0.000161	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.74e-05	0.000158	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.74e-05	0.000158	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.72e-05	0.000157	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.72e-05	0.000157	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.71e-05	0.000156	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CREBBP—urinary bladder cancer	1.7e-05	0.000154	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.69e-05	0.000153	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.68e-05	0.000153	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.68e-05	0.000152	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.67e-05	0.000152	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.65e-05	0.00015	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.59e-05	0.000145	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.57e-05	0.000143	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.56e-05	0.000142	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.55e-05	0.00014	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.55e-05	0.00014	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.52e-05	0.000139	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.49e-05	0.000135	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.48e-05	0.000135	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.48e-05	0.000134	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.47e-05	0.000134	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.47e-05	0.000134	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.46e-05	0.000133	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.45e-05	0.000132	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.43e-05	0.00013	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.42e-05	0.000129	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.41e-05	0.000128	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.4e-05	0.000127	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTGS2—urinary bladder cancer	1.39e-05	0.000126	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.39e-05	0.000126	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.37e-05	0.000124	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.35e-05	0.000123	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.29e-05	0.000117	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.27e-05	0.000116	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.24e-05	0.000113	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.23e-05	0.000112	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.23e-05	0.000112	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTEN—urinary bladder cancer	1.21e-05	0.00011	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.19e-05	0.000108	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.18e-05	0.000107	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.18e-05	0.000107	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.17e-05	0.000106	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.17e-05	0.000106	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.17e-05	0.000106	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.16e-05	0.000105	CbGpPWpGaD
Sertraline—MAOA—Metabolism—EP300—urinary bladder cancer	1.16e-05	0.000105	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.15e-05	0.000105	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.15e-05	0.000105	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.14e-05	0.000104	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.14e-05	0.000104	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.14e-05	0.000103	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.14e-05	0.000103	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.12e-05	0.000102	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.12e-05	0.000102	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.11e-05	0.000101	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.1e-05	0.0001	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.1e-05	9.98e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.09e-05	9.92e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.09e-05	9.88e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.08e-05	9.79e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.07e-05	9.76e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.07e-05	9.76e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.07e-05	9.74e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.06e-05	9.68e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.06e-05	9.68e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.06e-05	9.67e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.03e-05	9.38e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.03e-05	9.35e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.02e-05	9.27e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.01e-05	9.18e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.01e-05	9.16e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1e-05	9.13e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1e-05	9.1e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	9.9e-06	9e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.58e-06	8.71e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	9.49e-06	8.63e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	9.41e-06	8.55e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TYMS—urinary bladder cancer	9.21e-06	8.37e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.16e-06	8.33e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	9.1e-06	8.27e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	9.1e-06	8.27e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GPX1—urinary bladder cancer	8.71e-06	7.92e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	8.71e-06	7.92e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	8.56e-06	7.78e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PPARG—urinary bladder cancer	8.37e-06	7.61e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PPARG—urinary bladder cancer	8.17e-06	7.43e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	8.04e-06	7.31e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	8.04e-06	7.31e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CREBBP—urinary bladder cancer	7.85e-06	7.13e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PPARG—urinary bladder cancer	7.7e-06	7e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.64e-06	6.95e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PPARG—urinary bladder cancer	7.63e-06	6.94e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTEN—urinary bladder cancer	7.6e-06	6.91e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	7.4e-06	6.72e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	7.33e-06	6.66e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—EP300—urinary bladder cancer	7.25e-06	6.59e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.11e-06	6.46e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.02e-06	6.38e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.02e-06	6.38e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.73e-06	6.11e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.6e-06	6e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	6.58e-06	5.98e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PPARG—urinary bladder cancer	6.52e-06	5.93e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTGS2—urinary bladder cancer	6.43e-06	5.84e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	6.27e-06	5.69e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.21e-06	5.64e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	6.06e-06	5.5e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	6e-06	5.46e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTEN—urinary bladder cancer	5.74e-06	5.22e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTEN—urinary bladder cancer	5.6e-06	5.09e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—EP300—urinary bladder cancer	5.48e-06	4.98e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—EP300—urinary bladder cancer	5.35e-06	4.86e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTEN—urinary bladder cancer	5.28e-06	4.8e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTEN—urinary bladder cancer	5.24e-06	4.76e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	5.13e-06	4.66e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—EP300—urinary bladder cancer	5.04e-06	4.58e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.03e-06	4.57e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.99e-06	4.54e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.84e-06	4.39e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTEN—urinary bladder cancer	4.47e-06	4.07e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—EP300—urinary bladder cancer	4.27e-06	3.88e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.96e-06	3.6e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.45e-06	3.14e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.29e-06	2.99e-05	CbGpPWpGaD
